Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jazz Pharmaceuticals - 17 Year Stock Price History | JAZZ

Historical daily share price chart and data for Jazz Pharmaceuticals since 2007 adjusted for splits and dividends. The latest closing stock price for Jazz Pharmaceuticals as of December 17, 2024 is 122.49.
  • The all-time high Jazz Pharmaceuticals stock closing price was 193.02 on July 28, 2015.
  • The Jazz Pharmaceuticals 52-week high stock price is 134.17, which is 9.5% above the current share price.
  • The Jazz Pharmaceuticals 52-week low stock price is 99.06, which is 19.1% below the current share price.
  • The average Jazz Pharmaceuticals stock price for the last 52 weeks is 114.76.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Jazz Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 114.5788 126.9300 132.7700 100.5700 122.4900 -0.41%
2023 135.0766 156.3600 160.4700 114.2600 123.0000 -22.79%
2022 149.4266 131.0100 168.6600 126.5900 159.3100 25.05%
2021 154.8860 160.4000 186.4200 119.8700 127.4000 -22.81%
2020 128.2596 148.4300 165.0500 87.7400 165.0500 10.56%
2019 133.7751 125.1300 153.7300 117.6500 149.2800 20.43%
2018 157.7279 137.4000 183.1800 115.9400 123.9600 -7.94%
2017 143.3267 111.4600 162.0100 111.4600 134.6500 23.50%
2016 129.6499 137.2600 157.1600 96.7400 109.0300 -22.43%
2015 165.3651 163.4300 193.0200 121.9400 140.5600 -14.15%
2014 152.3077 126.7800 183.0300 124.6300 163.7300 29.37%
2013 75.9082 54.5800 126.7900 52.7900 126.5600 137.67%
2012 48.9650 38.5900 59.3400 38.5900 53.2501 37.85%
2011 33.3224 19.9600 46.8000 19.4300 38.6300 96.29%
2010 10.9546 8.2400 20.0000 7.1500 19.6800 149.75%
2009 4.2554 2.0000 10.3700 0.5500 7.8800 308.29%
2008 7.3328 14.8000 15.4600 1.0100 1.9300 -86.87%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.438B $3.834B
Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Sativex is approved in the U.K. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. It received approval for two new drugs' Zepzelca & Rylaze'.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.467B 14.08
Vertex Pharmaceuticals (VRTX) United States $119.424B 0.00
Gilead Sciences (GILD) United States $114.476B 20.73
Bristol Myers Squibb (BMY) United States $113.132B 47.68
CSL (CSLLY) Australia $84.940B 0.00
Regeneron Pharmaceuticals (REGN) United States $80.363B 18.29
GSK (GSK) United Kingdom $70.363B 8.14
Argenex SE (ARGX) Netherlands $36.656B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.657B 0.00
BioNTech SE (BNTX) Germany $28.617B 0.00
Illumina (ILMN) United States $22.818B 83.16
Biogen (BIIB) United States $21.862B 9.39
BeiGene (BGNE) Cayman Islands $17.475B 0.00
Moderna (MRNA) United States $16.097B 0.00
Genmab (GMAB) Denmark $13.348B 19.58
Incyte (INCY) United States $13.206B 0.00
Insmed (INSM) United States $12.815B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.580B 29.21
Bio-Techne Corp (TECH) United States $12.027B 46.44
Sarepta Therapeutics (SRPT) United States $11.817B 106.65
Exact Sciences (EXAS) United States $11.336B 0.00
Vaxcyte (PCVX) United States $10.933B 0.00
QIAGEN (QGEN) Netherlands $10.360B 21.31
Exelixis (EXEL) United States $10.004B 22.75
Bio-Rad Laboratories (BIO.B) United States $9.437B 32.07
Intra-Cellular Therapies (ITCI) United States $8.803B 0.00
Repligen (RGEN) United States $8.763B 114.17
Roivant Sciences (ROIV) United Kingdom $8.619B 0.00
Ascendis Pharma (ASND) Denmark $7.876B 0.00
Revolution Medicines (RVMD) United States $7.572B 0.00
Legend Biotech (LEGN) United States $6.414B 0.00
Nuvalent (NUVL) United States $6.172B 0.00
Halozyme Therapeutics (HALO) United States $6.107B 13.79
Blueprint Medicines (BPMC) United States $5.920B 0.00
Cytokinetics (CYTK) United States $5.741B 0.00
Telix Pharmaceuticals (TLX) Australia $5.275B 0.00
Viking Therapeutics (VKTX) United States $5.241B 0.00
TG Therapeutics (TGTX) United States $4.984B 0.00
Alkermes (ALKS) Ireland $4.937B 16.58
Krystal Biotech (KRYS) United States $4.706B 77.92
Arcellx (ACLX) United States $4.531B 0.00
ADMA Biologics Inc (ADMA) United States $4.394B 46.47
Axsome Therapeutics (AXSM) United States $4.366B 0.00
Guardant Health (GH) United States $4.295B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.228B 0.00
Apellis Pharmaceuticals (APLS) United States $4.129B 0.00
Scholar Rock Holding (SRRK) United States $3.930B 0.00
Biohaven (BHVN) United States $3.890B 0.00
Avidity Biosciences (RNA) United States $3.876B 0.00
Immunovant (IMVT) United States $3.858B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.737B 0.00
NovoCure (NVCR) Jersey $3.615B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.395B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.365B 0.00
Denali Therapeutics (DNLI) United States $3.306B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.281B 0.00
Janux Therapeutics (JANX) United States $3.207B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.053B 0.00
Merus (MRUS) Netherlands $2.932B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.872B 22.13
Zai Lab (ZLAB) China $2.860B 0.00
SpringWorks Therapeutics (SWTX) United States $2.849B 0.00
Vericel (VCEL) United States $2.837B 957.83
Twist Bioscience (TWST) United States $2.819B 0.00
Amicus Therapeutics (FOLD) United States $2.797B 0.00
Vera Therapeutics (VERA) United States $2.789B 0.00
Kymera Therapeutics (KYMR) United States $2.729B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.719B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.716B 0.00
Edgewise Therapeutics (EWTX) United States $2.615B 0.00
Protagonist Therapeutics (PTGX) United States $2.448B 15.44
Iovance Biotherapeutics (IOVA) United States $2.386B 0.00
Geron (GERN) United States $2.333B 0.00
Beam Therapeutics (BEAM) United States $2.313B 0.00
NeoGenomics (NEO) United States $2.276B 0.00
Agios Pharmaceuticals (AGIO) United States $2.222B 0.00
Ligand Pharmaceuticals (LGND) United States $2.209B 55.15
IDEAYA Biosciences (IDYA) United States $2.177B 0.00
Bavarian Nordic (BVNRY) Denmark $2.155B 13.20
WAVE Life Sciences (WVE) Singapore $2.050B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.037B 0.00
Akero Therapeutics (AKRO) United States $2.016B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.007B 0.00
Apogee Therapeutics (APGE) United States $2.004B 0.00
ImmunityBio (IBRX) United States $2.000B 0.00
CG Oncology (CGON) United States $1.945B 0.00
Disc Medicine (IRON) United States $1.931B 0.00
Belite Bio (BLTE) United States $1.908B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.847B 15.35
Certara (CERT) United States $1.846B 52.14
MannKind (MNKD) United States $1.804B 46.71
Fortrea Holdings (FTRE) United States $1.794B 57.14
Structure Therapeutics (GPCR) United States $1.789B 0.00
Galapagos (GLPG) Belgium $1.767B 0.00
Dynavax Technologies (DVAX) United States $1.704B 99.69
Celldex Therapeutics (CLDX) United States $1.686B 0.00
Neumora Therapeutics (NMRA) United States $1.667B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.485B 0.00
Arcus Biosciences (RCUS) United States $1.472B 0.00
Novavax (NVAX) United States $1.459B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.458B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.446B 0.00
Nurix Therapeutics (NRIX) United States $1.436B 0.00
Viridian Therapeutics (VRDN) United States $1.414B 0.00
Travere Therapeutics (TVTX) United States $1.352B 0.00
MiMedx (MDXG) United States $1.346B 35.23
Mesoblast (MESO) Australia $1.343B 0.00
Arvinas (ARVN) United States $1.340B 0.00
Intellia Therapeutics (NTLA) United States $1.314B 0.00
Myriad Genetics (MYGN) United States $1.314B 0.00
Praxis Precision Medicines (PRAX) United States $1.308B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.286B 0.00
Spyre Therapeutics (SYRE) United States $1.241B 0.00
ANI Pharmaceuticals (ANIP) United States $1.190B 16.21
Syndax Pharmaceuticals (SNDX) United States $1.189B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.096B 0.00
Upstream Bio (UPB) United States $1.085B 0.00
Vir Biotechnology (VIR) United States $1.026B 0.00
Septerna (SEPN) United States $0.994B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.954B 0.00
Bicara Therapeutics (BCAX) United States $0.952B 0.00
Poseida Therapeutics (PSTX) United States $0.930B 0.00
Adaptive Biotechnologies (ADPT) United States $0.930B 0.00
Liquidia Technologies (LQDA) United States $0.924B 0.00
Pacira BioSciences (PCRX) United States $0.917B 8.63
Gyre Therapeutics (GYRE) United States $0.902B 0.00
ArriVent BioPharma (AVBP) United States $0.900B 0.00
Cogent Biosciences (COGT) United States $0.900B 0.00
Nuvation Bio (NUVB) United States $0.878B 0.00
Zymeworks (ZYME) United States $0.866B 0.00
Immatics (IMTX) Germany $0.861B 0.00
Replimune (REPL) United States $0.859B 0.00
LENZ Therapeutics (LENZ) United States $0.852B 0.00
AbCellera Biologics (ABCL) Canada $0.830B 0.00
89BIO (ETNB) United States $0.816B 0.00
Pliant Therapeutics (PLRX) United States $0.809B 0.00
Castle Biosciences (CSTL) United States $0.809B 144.35
Cytek Biosciences (CTKB) United States $0.800B 0.00
Avid Bioservices (CDMO) United States $0.789B 0.00
Immunome (IMNM) United States $0.785B 0.00
Keros Therapeutics (KROS) United States $0.763B 0.00
Tyra Biosciences (TYRA) United States $0.756B 0.00
UniQure (QURE) Netherlands $0.751B 0.00
Kura Oncology (KURA) United States $0.749B 0.00
GRAIL (GRAL) United States $0.745B 0.00
Erasca (ERAS) United States $0.724B 0.00
Anavex Life Sciences (AVXL) United States $0.717B 0.00
CureVac (CVAC) Germany $0.707B 5.75
Dianthus Therapeutics (DNTH) United States $0.705B 0.00
Oculis Holding AG (OCS) Switzerland $0.692B 0.00
Prothena (PRTA) Ireland $0.688B 0.00
Rapport Therapeutics (RAPP) United States $0.687B 0.00
Cullinan Therapeutics (CGEM) United States $0.684B 0.00
Tectonic Therapeutic (TECX) United States $0.669B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.663B 0.00
Entrada Therapeutics (TRDA) United States $0.661B 11.11
Arbutus Biopharma (ABUS) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.639B 0.00
MBX Biosciences (MBX) United States $0.633B 0.00
CARGO Therapeutics (CRGX) United States $0.632B 0.00
Pharming Group (PHAR) Netherlands $0.609B 0.00
Oric Pharmaceuticals (ORIC) United States $0.601B 0.00
Mineralys Therapeutics (MLYS) United States $0.592B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.580B 0.00
Terns Pharmaceuticals (TERN) United States $0.572B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.543B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.539B 0.00
Astria Therapeutics (ATXS) United States $0.537B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.525B 0.00
Humacyte (HUMA) United States $0.516B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.509B 0.00
CorMedix Inc (CRMD) United States $0.508B 0.00
Third Harmonic Bio (THRD) United States $0.507B 0.00
PureTech Health (PRTC) United States $0.487B 0.00
MeiraGTx Holdings (MGTX) United States $0.478B 0.00
Cartesian Therapeutics (RNAC) United States $0.475B 0.00
AnaptysBio (ANAB) United States $0.474B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.474B 0.00
Annexon (ANNX) United States $0.473B 0.00
ChromaDex (CDXC) United States $0.467B 612.00
Arcturus Therapeutics Holdings (ARCT) United States $0.466B 0.00
Celcuity (CELC) United States $0.465B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.464B 0.00
Emergent Biosolutions (EBS) United States $0.459B 0.00
MaxCyte (MXCT) United States $0.452B 0.00
Abivax SA (ABVX) France $0.450B 0.00
Codexis (CDXS) United States $0.450B 0.00
Kodiak Sciences (KOD) United States $0.446B 0.00
Alpha Teknova (TKNO) United States $0.428B 0.00
Sangamo Therapeutics (SGMO) United States $0.428B 0.00
IGM Biosciences (IGMS) United States $0.426B 0.00
Absci (ABSI) United States $0.424B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.422B 0.00
Sana Biotechnology (SANA) United States $0.422B 0.00
Aura Biosciences (AURA) United States $0.420B 0.00
REGENXBIO (RGNX) United States $0.410B 0.00
GH Research (GHRS) Ireland $0.403B 0.00
Allogene Therapeutics (ALLO) United States $0.396B 0.00
Alumis (ALMS) United States $0.396B 0.00
Olema Pharmaceuticals (OLMA) United States $0.387B 0.00
Northwest Biotherapeutics (NWBO) United States $0.385B 0.00
Prime Medicine (PRME) United States $0.378B 0.00
Zenas BioPharma (ZBIO) United States $0.373B 0.00
Contineum Therapeutics (CTNM) United States $0.362B 0.00
Neurogene (NGNE) United States $0.349B 0.00
Voyager Therapeutics (VYGR) United States $0.343B 8.83
Kamada (KMDA) Israel $0.337B 20.96
Sage Therapeutics (SAGE) United States $0.329B 0.00
Tango Therapeutics (TNGX) United States $0.329B 0.00
ACELYRIN, INC (SLRN) United States $0.324B 0.00
Revance Therapeutics (RVNC) United States $0.323B 0.00
Trevi Therapeutics (TRVI) United States $0.321B 0.00
XOMA Royalty (XOMA) United States $0.320B 0.00
Eton Pharmaceuticals (ETON) United States $0.319B 0.00
Prima BioMed (IMMP) Australia $0.317B 0.00
Design Therapeutics (DSGN) United States $0.317B 0.00
C4 Therapeutics (CCCC) United States $0.309B 0.00
Jasper Therapeutics (JSPR) United States $0.309B 0.00
Foghorn Therapeutics (FHTX) United States $0.295B 0.00
AC Immune (ACIU) Switzerland $0.292B 0.00
BioStem Technologies (BSEM) $0.286B 25.31
ITeos Therapeutics (ITOS) United States $0.281B 0.00
Lifecore Biomedical (LFCR) United States $0.280B 0.00
Renovaro (RENB) United States $0.279B 0.00
Benitec Biopharma (BNTC) United States $0.273B 0.00
EnGene Holdings (ENGN) Canada $0.269B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.269B 0.00
Urogen Pharma (URGN) United States $0.266B 0.00
Rezolute (RZLT) United States $0.266B 0.00
Mersana Therapeutics (MRSN) United States $0.266B 0.00
Chimerix (CMRX) United States $0.265B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.262B 0.00
Artiva Biotherapeutics (ARTV) United States $0.258B 0.00
ATyr Pharma (ATYR) United States $0.257B 0.00
Abeona Therapeutics (ABEO) United States $0.256B 0.00
Anika Therapeutics (ANIK) United States $0.251B 0.00
Ocugen (OCGN) United States $0.250B 0.00
Atea Pharmaceuticals (AVIR) United States $0.247B 0.00
Nautilus Biotechnology (NAUT) United States $0.245B 0.00
Innate Pharma S.A (IPHA) France $0.245B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.231B 0.00
DiaMedica Therapeutics (DMAC) United States $0.230B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.220B 0.00
Candel Therapeutics (CADL) United States $0.219B 0.00
Molecular Partners AG (MOLN) Switzerland $0.219B 0.00
Tenaya Therapeutics (TNYA) United States $0.218B 0.00
Fulcrum Therapeutics (FULC) United States $0.214B 0.00
XBiotech (XBIT) United States $0.212B 0.00
Inhibrx Biosciences (INBX) United States $0.212B 0.00
Gossamer Bio (GOSS) United States $0.211B 0.00
TuHURA Biosciences (HURA) United States $0.208B 0.00
Fate Therapeutics (FATE) United States $0.208B 0.00
Biomea Fusion (BMEA) United States $0.204B 0.00
Compass Therapeutics (CMPX) United States $0.201B 0.00
Cardiff Oncology (CRDF) United States $0.200B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.200B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.200B 0.00
Verastem (VSTM) United States $0.199B 0.00
Precigen (PGEN) United States $0.198B 0.00
Solid Biosciences (SLDB) United States $0.196B 0.00
Inozyme Pharma (INZY) United States $0.195B 0.00
Alector (ALEC) United States $0.193B 0.00
GENFIT S.A (GNFT) France $0.191B 0.00
Kyverna Therapeutics (KYTX) United States $0.191B 0.00
Opthea (OPT) Australia $0.190B 0.00
Amarin (AMRN) Ireland $0.187B 0.00
Coherus BioSciences (CHRS) United States $0.185B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.183B 0.00
Bright Minds Biosciences (DRUG) United States $0.182B 0.00
Checkpoint Therapeutics (CKPT) United States $0.179B 0.00
Greenwich LifeSciences (GLSI) United States $0.178B 0.00
Semper Paratus Acquisition (TVGN) United States $0.175B 0.00
Sutro Biopharma (STRO) United States $0.175B 0.00
Climb Bio (CLYM) United States $0.175B 0.00
Caribou Biosciences (CRBU) United States $0.173B 0.00
2seventy Bio (TSVT) United States $0.169B 0.00
Actuate Therapeutics (ACTU) United States $0.168B 0.00
Adherex Technologies (FENC) United States $0.166B 0.00
Nkarta (NKTX) United States $0.165B 0.00
Cidara Therapeutics (CDTX) United States $0.161B 0.00
Ventyx Biosciences (VTYX) United States $0.161B 0.00
ScPharmaceuticals (SCPH) United States $0.160B 0.00
CAMP4 Therapeutics (CAMP) United States $0.154B 0.00
BioAge Labs (BIOA) United States $0.153B 0.00
PepGen (PEPG) United States $0.153B 0.00
TScan Therapeutics (TCRX) United States $0.152B 0.00
Seres Therapeutics (MCRB) United States $0.150B 0.00
Zura Bio (ZURA) United States $0.149B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.148B 0.00
Seer (SEER) United States $0.146B 0.00
Black Diamond Therapeutics (BDTX) United States $0.145B 0.00
Compugen (CGEN) Israel $0.144B 80.50
Instil Bio (TIL) United States $0.143B 0.00
Elutia (ELUT) United States $0.143B 0.00
Puma Biotechnology (PBYI) United States $0.141B 6.00
InflaRx (IFRX) Germany $0.139B 0.00
Cabaletta Bio (CABA) United States $0.138B 0.00
Sagimet Biosciences (SGMT) United States $0.135B 0.00
Monopar Therapeutics (MNPR) United States $0.134B 0.00
Applied Therapeutics (APLT) United States $0.134B 0.00
Inventiva S.A (IVA) France $0.129B 0.00
Aligos Therapeutics (ALGS) United States $0.122B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.122B 0.00
Editas Medicine (EDIT) United States $0.119B 0.00
X4 Pharmaceuticals (XFOR) United States $0.114B 0.00
Leap Therapeutics (LPTX) United States $0.113B 0.00
Akoya Biosciences (AKYA) United States $0.113B 0.00
Adverum Biotechnologies (ADVM) United States $0.112B 0.00
TELA Bio (TELA) United States $0.109B 0.00
INmune Bio (INMB) United States $0.105B 0.00
Alto Neuroscience (ANRO) United States $0.103B 0.00
MediciNova (MNOV) United States $0.103B 0.00
Skye Bioscience (SKYE) United States $0.103B 0.00
Immunic (IMUX) United States $0.102B 0.00
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.099B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
Cellectis S.A (CLLS) France $0.098B 0.00
HilleVax (HLVX) United States $0.098B 0.00
Scilex Holding (SCLX) United States $0.097B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.096B 0.00
Rani Therapeutics Holdings (RANI) United States $0.095B 0.00
Invizyne Technologies (IZTC) United States $0.095B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.094B 0.00
Genenta Science S.p.A (GNTA) Italy $0.094B 0.00
Allakos (ALLK) United States $0.094B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.092B 0.00
Adagene (ADAG) China $0.091B 0.00
Nuvectis Pharma (NVCT) United States $0.091B 0.00
Quince Therapeutics (QNCX) United States $0.089B 0.00
23andMe Holding (ME) United States $0.088B 0.00
CytomX Therapeutics (CTMX) United States $0.087B 6.53
Adlai Nortye (ANL) Cayman Islands $0.085B 0.00
I-Mab (IMAB) China $0.082B 0.00
Vigil Neuroscience (VIGL) United States $0.081B 0.00
Genelux (GNLX) United States $0.080B 0.00
Ikena Oncology (IKNA) United States $0.080B 0.00
Adicet Bio (ACET) United States $0.080B 0.00
Abpro Holdings (ABP) United States $0.079B 0.00
Generation Bio (GBIO) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Entera Bio (ENTX) Israel $0.077B 0.00
FibroBiologics (FBLG) United States $0.077B 0.00
ALX Oncology Holdings (ALXO) United States $0.076B 0.00
Repare Therapeutics (RPTX) Canada $0.075B 0.00
Werewolf Therapeutics (HOWL) United States $0.074B 0.00
DBV Technologies S.A (DBVT) France $0.073B 0.00
Annovis Bio (ANVS) United States $0.073B 0.00
Ovid Therapeutics (OVID) United States $0.073B 0.00
Aerovate Therapeutics (AVTE) United States $0.073B 0.00
Agenus (AGEN) United States $0.072B 0.00
ZIVO Bioscience (ZIVO) United States $0.070B 0.00
BioAtla (BCAB) United States $0.070B 0.00
Theratechnologies (THTX) Canada $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.069B 0.00
PDS Biotechnology (PDSB) United States $0.069B 0.00
Vor Biopharma (VOR) $0.068B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
Invivyd (IVVD) United States $0.065B 0.00
BeyondSpring (BYSI) United States $0.064B 0.00
Oncolytics Biotech (ONCY) Canada $0.063B 0.00
BGM Group (BGM) China $0.062B 0.00
Connect Biopharma Holdings (CNTB) United States $0.062B 0.00
Bluebird Bio (BLUE) United States $0.062B 0.00
Galena Biopharma (SLS) United States $0.061B 0.00
Inovio Pharmaceuticals (INO) United States $0.061B 0.00
Cue Biopharma (CUE) United States $0.060B 0.00
Atara Biotherapeutics (ATRA) United States $0.060B 0.00
Aadi Bioscience (AADI) United States $0.059B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
Spero Therapeutics (SPRO) United States $0.058B 15.29
Immix Biopharma (IMMX) United States $0.056B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.056B 0.00
Boundless Bio (BOLD) United States $0.055B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Shattuck Labs (STTK) United States $0.054B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.054B 0.00
Omega Therapeutics (OMGA) United States $0.054B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
IO Biotech (IOBT) Denmark $0.053B 0.00
Enzo Biochem (ENZ) United States $0.053B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.051B 0.00
Immuneering (IMRX) United States $0.051B 0.00
Kezar Life Sciences (KZR) United States $0.049B 0.00
Aileron Therapeutics (ALRN) United States $0.049B 0.00
Celularity (CELU) United States $0.049B 0.00
Dyadic (DYAI) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Passage Bio (PASG) United States $0.047B 0.00
Exicure (XCUR) United States $0.045B 0.00
Q32 Bio (QTTB) United States $0.045B 0.00
Rallybio (RLYB) United States $0.045B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
AN2 Therapeutics (ANTX) United States $0.043B 0.00
Xilio Therapeutics (XLO) United States $0.043B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.042B 0.00
Precision BioSciences (DTIL) United States $0.042B 0.00
Clene (CLNN) United States $0.041B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.039B 0.00
SAB Biotherapeutics (SABS) United States $0.038B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
CalciMedica (CALC) United States $0.037B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.036B 0.00
Grace Therapeutics (GRCE) Canada $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Affimed (AFMD) Germany $0.035B 0.00
Forte Biosciences (FBRX) United States $0.034B 0.00
Beyond Air (XAIR) United States $0.034B 0.00
OnKure Therapeutics (OKUR) United States $0.033B 0.00
Alpha Cognition (ACOG) Canada $0.033B 0.00
Opus Genetics (IRD) United States $0.032B 0.00
Rapt Therapeutics (RAPT) United States $0.032B 0.00
RenovoRx (RNXT) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
NextCure (NXTC) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.030B 0.00
Intensity Therapeutics (INTS) United States $0.029B 0.00
KALA BIO (KALA) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Longeveron (LGVN) United States $0.028B 0.00
Femasys (FEMY) United States $0.027B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Gelteq (GELS) Australia $0.026B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
Senti Biosciences (SNTI) United States $0.026B 0.00
Equillium (EQ) United States $0.025B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
MiNK Therapeutics (INKT) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
BRIACELL THERAP (BCTX) Canada $0.024B 0.00
Ocean Biomedical (OCEA) United States $0.024B 0.00
LakeShore Biopharma (LSB) China $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Athira Pharma (ATHA) United States $0.023B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
IN8bio (INAB) United States $0.021B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
Tenax Therapeutics (TENX) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
MetaVia (MTVA) United States $0.019B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.018B 0.00
NKGen Biotech (NKGN) United States $0.018B 0.00
BioXcel Therapeutics (BTAI) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Prana Biotechnology (ATHE) Australia $0.018B 0.00
Aprea Therapeutics (APRE) United States $0.017B 0.00
Cyclo Therapeutics (CYTH) United States $0.017B 0.00
Spruce Biosciences (SPRB) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
BioAffinity Technologies (BIAF) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
Cara Therapeutics (CARA) United States $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Imunon (IMNN) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.012B 0.00
CervoMed (CRVO) United States $0.012B 0.00
Aptose Biosciences (APTO) Canada $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Mainz Biomed (MYNZ) Germany $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Apollomics (APLM) United States $0.009B 0.00
Aytu BioPharma (AYTU) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.008B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Ensysce Biosciences (ENSC) United States $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Evaxion Biotech (EVAX) Denmark $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Vincerx Pharma (VINC) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Carmell (CTCX) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Portage Biotech (PRTG) $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Palisade Bio (PALI) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
AquaBounty Technologies (AQB) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00